Source: SiliconRepublic

OncoMark: OncoMark raises €2.1m to get breast cancer tool to market

A new breast cancer diagnostic test is nearing the market after OncoMark, a UCD-based start-up, successfully raised €2.1m.The post OncoMark raises €2.1m to get breast cancer tool to market appeared first on Silicon Republic.

Read full article »

OncoMark's Competitors | OncoMark's News | OncoMark's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Desmond O 'Leary

CEO Approval Rating

90/100

OncoMark is an Ireland-based molecular diagnostics company that develops and commercializes cancer biomarkers for the detection and treatment of breast cancer.